Human Longevity, Inc. (HLI) Acquires Cypher Genomics, Inc.

Cypher CEO, Ashley Van Zeeland, Ph.D. to become head of HLI’s Pediatric Business

(SAN DIEGO, CA)—November 30, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions. The San Diego-based company has 14 employees who will join HLI including Cypher CEO and Co-founder, Ashley Van Zeeland, Ph.D., who is now the head of HLI’s Pediatric Business. Financial details of the deal were not disclosed.

Continue Reading →

Human Longevity, Inc. and Venter Institute Scientists Publish Paper Demonstrating Inconsistency in Microbiome Studies due to Variable Approaches to DNA Sequencing and Data Analysis

Comparison of four common library prep methods found significant differences in types of microbes uncovered and showed biases in error and duplication rates

(SAN DIEGO, CA)—October 26, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that its researchers along with those from the J. Craig Venter Institute and the University of California, San Diego, have published a paper in the journal, Proceedings of the National Academy of Sciences (PNAS), outlining the confusing and conflicting microbiome results generated by a variety of next generation sequencing technology. They also outline recommendations for new research community standards in the microbiome research field given these differences. The paper is being published this week in the early online edition of PNAS.

Continue Reading →

Human Longevity, Inc. Launches the Health Nucleus, a Comprehensive and Personalized Health Platform for Individuals

(SAN DIEGO, CA) OCTOBER 13, 2015 – Human Longevity, Inc. (HLI), the genomics-based, technology-driven company working to revolutionize the practice of medicine, announced today the launch of the company’s first Health Nucleus™, a genomic powered clinical research project that has the potential to transform healthcare. The inaugural Health Nucleus is located in San Diego, CA, at HLI’s headquarters facility. More Health Nucleus facilities are slated to open in 2016 in other US and International cities.

Continue Reading →

Human Longevity, Inc. and Discovery Ltd to Offer Whole Exome, Whole Genome and Cancer Genome Sequencing to Discovery Insurance Clients in South Africa and the United Kingdom

HLI Introduces a Whole Exome Sequencing Product for $250 USD

(SAN DIEGO, CA and SANDTON, SOUTH AFRICA)—September 22, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, and Discovery Ltd, a pioneering insurer dedicated to making people healthier, announced today that the two companies have entered into a multi-year agreement to offer whole exome, whole genome and cancer genome sequencing to Discovery’s clients in South Africa and the United Kingdom.
Continue Reading →

Human Longevity, Inc. Announces Research Fellows Program

Program Gives Experts from Several Disciplines Unique Opportunity to Advance Human Genomic Understanding

Application Deadline is September 1, 2015

LA JOLLA, CA – Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today the HLI Research Fellows Program, designed to engage experts in the fields of genomics, informatics/bioinformatics, and machine learning to explore the latest findings and knowledge on genetics with clinically relevant outcomes.  The program gives scholars a unique opportunity to participate in innovative analysis of large scale genome data and to work with groups of scientists, bioinformaticians and machine learning specialists to ensure state-of-the-art annotation and interpretation of the human genome.

Continue Reading →

Page 2 of 4 1234